Bjerre, M.T.; Nørgaard, M.; Larsen, O.H.; Jensen, S.Ø.; Strand, S.H.; Østergren, P.; Fode, M.; Fredsøe, J.; Ulhøi, B.P.; Mortensen, M.M.;
et al. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential. Cells 2020, 9, 1362.
https://doi.org/10.3390/cells9061362
AMA Style
Bjerre MT, Nørgaard M, Larsen OH, Jensen SØ, Strand SH, Østergren P, Fode M, Fredsøe J, Ulhøi BP, Mortensen MM,
et al. Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential. Cells. 2020; 9(6):1362.
https://doi.org/10.3390/cells9061362
Chicago/Turabian Style
Bjerre, Marianne Trier, Maibritt Nørgaard, Ole Halfdan Larsen, Sarah Østrup Jensen, Siri H. Strand, Peter Østergren, Mikkel Fode, Jacob Fredsøe, Benedicte Parm Ulhøi, Martin Mørck Mortensen,
and et al. 2020. "Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential" Cells 9, no. 6: 1362.
https://doi.org/10.3390/cells9061362
APA Style
Bjerre, M. T., Nørgaard, M., Larsen, O. H., Jensen, S. Ø., Strand, S. H., Østergren, P., Fode, M., Fredsøe, J., Ulhøi, B. P., Mortensen, M. M., Jensen, J. B., Borre, M., & Sørensen, K. D.
(2020). Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential. Cells, 9(6), 1362.
https://doi.org/10.3390/cells9061362